Methocarbamol liquid 100mg/ml, RX, glass vial
FDA Drug Recall #D-0400-2019 — Class II — January 2, 2019
Recall Summary
| Recall Number | D-0400-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 2, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Hiers Enterprises, LLC dba Northwest Compounding Pharmacy |
| Location | Roseburg, OR |
| Product Type | Drugs |
| Quantity | 300 ml |
Product Description
Methocarbamol liquid 100mg/ml, RX, glass vial
Reason for Recall
Lack of sterility assurance.
Distribution Pattern
Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.
Lot / Code Information
10082018@34 exp 1/6/19, 10312018@27 exp 1/29/19
Other Recalls from Hiers Enterprises, LLC dba Northwest ...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0397-2019 | Class II | Lidocaine gel 2%, RX, plastic dropper | Jan 2, 2019 |
| D-0396-2019 | Class II | Hydroxyprogesterone liquid, 250mg/ml, RX, glass... | Jan 2, 2019 |
| D-0407-2019 | Class II | Glutathione liquid, 200mg/ml, Rx | Jan 2, 2019 |
| D-0399-2019 | Class II | MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX gla... | Jan 2, 2019 |
| D-0408-2019 | Class II | Lidocaine gel 1%, RX, plastic dropper | Jan 2, 2019 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.